参仙升脉液活血化瘀药效学研究  

Blood_Flow_Activating and Blood_Stasis_Removing Actions of Shenxian Shengmai Ye

作　　者：席时芳[1] 吴淑荣[2] 闫小军 郭茵 施雪筠[1] 龙致贤[1] 刘爱鸾 

机构地区：[1]北京中医药大学,北京100029 [2]北京市临床药学研究所,北京100035

出　　处：《中药新药与临床药理》1999年第4期211-212,共2页Traditional Chinese Drug Research and Clinical Pharmacology

摘　　要：为了观察参仙升脉液活血化瘀的药效作用 ,进行大鼠体外血小板聚集实验。结果显示参仙升脉液能显著抑制ADP诱导血小板聚集作用 (P <0 .0 0 1 ) ;小鼠体内激光致栓实验 ,结果表明参仙升脉液能明显延长小鼠耳静脉激光致栓的初栓及全栓形成时间 (P <0 .0 0 1 )。Platelet aggregation test in vitro was carried on in mice to observe blood_flow_activating and blood_stasis_removing actions of Shenxian Shengmai Ye (SSY).Results showed that SSY could significantly inhibit the platelet aggregation induced by adenosine diphosphate(P< 0.001 ).The in_vivo laser_induced thrombogenesis in mice showed that SSY could remarkably prolong the initial and total thrombogenic times in the auricular veins of mice(P< 0.001 ).

关 键 词：参仙升脉液 药理学 活血化瘀 

分 类 号：R285.5[医药卫生—中药学] R255.705[医药卫生—中医学]